A common Lithuanian mutation causing familial hypercholesterolemia in Ashkenazi Jews.

V Meiner, D Landsberger, N Berkman… - American journal of …, 1991 - ncbi.nlm.nih.gov
V Meiner, D Landsberger, N Berkman, A Reshef, P Segal, HC Seftel…
American journal of human genetics, 1991ncbi.nlm.nih.gov
Familial hypercholesterolemia (FH) is an autosomal dominant disease caused by mutations
in the low-density-lipoprotein (LDL) receptor. Here we characterize an LDL-receptor founder
mutation that is associated with a distinct LDL-receptor haplotype and is responsible for FH
in 35% of 71 Jewish-Ashkenazi FH families in Israel. Sixty four percent (16/25) of the
Ashkenazi patients who carry this mutant allele were of Lithuanian origin. The mutation was
not found in 47 non-Ashkenazi FH families. This mutation was prevalent (8/10 FH cases) in …
Abstract
Familial hypercholesterolemia (FH) is an autosomal dominant disease caused by mutations in the low-density-lipoprotein (LDL) receptor. Here we characterize an LDL-receptor founder mutation that is associated with a distinct LDL-receptor haplotype and is responsible for FH in 35% of 71 Jewish-Ashkenazi FH families in Israel. Sixty four percent (16/25) of the Ashkenazi patients who carry this mutant allele were of Lithuanian origin. The mutation was not found in 47 non-Ashkenazi FH families. This mutation was prevalent (8/10 FH cases) in the Jewish community in South Africa, which originated mainly from Lithuania. The mutation, a 3-bp in-frame deletion that would result in the elimination of Gly197, has been previously designated FH-Piscataway. PCR amplification of a DNA fragment that includes the mutation in heterozygous individuals results in the formation of a heteroduplex that can be demonstrated by PAGE and used for molecular diagnosis.
ncbi.nlm.nih.gov